Eikelboom JW - Search Results

1

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease.

Liang Y, Zhu J, Liu L, Anand SS, Connolly SJ, Bosch J, Guzik TJ, O'Donnell M, Dagenais GR, Fox KA, Shestakovska O, Berkowitz SD, Muehlhofer E, Keller L, Yusuf S, Eikelboom JW; COMPASS Investigators. Liang Y, et al. Among authors: eikelboom jw. Cardiovasc Res. 2021 Feb 22;117(3):942-949. doi: 10.1093/cvr/cvaa100. Cardiovasc Res. 2021. PMID: 32289159 Clinical Trial.

2

Low rates of preventive practices in patients with peripheral vascular disease.

Anand SS, Kundi A, Eikelboom J, Yusuf S. Anand SS, et al. Can J Cardiol. 1999 Nov;15(11):1259-63. Can J Cardiol. 1999. PMID: 10579741

3

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.

Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Eikelboom JW, et al. Circulation. 2002 Apr 9;105(14):1650-5. doi: 10.1161/01.cir.0000013777.21160.07. Circulation. 2002. PMID: 11940542

4

Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness.

Ho WK, Hankey GJ, Eikelboom JW. Ho WK, et al. Among authors: eikelboom jw. Expert Opin Pharmacother. 2004 Mar;5(3):493-503. doi: 10.1517/14656566.5.3.493. Expert Opin Pharmacother. 2004. PMID: 15013918 Review.

5

Antiplatelet agents in acute coronary syndromes.

Eikelboom JW, Anand S. Eikelboom JW, et al. Semin Vasc Med. 2003 Nov;3(4):403-14. doi: 10.1055/s-2004-817689. Semin Vasc Med. 2003. PMID: 15199447 Review.

6

Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes.

Mehta SR, Eikelboom JW, Demers C, Maggioni AP, Commerford PJ, Yusuf S. Mehta SR, et al. Among authors: eikelboom jw. Can J Physiol Pharmacol. 2005 Jan;83(1):98-103. doi: 10.1139/y05-003. Can J Physiol Pharmacol. 2005. PMID: 15759056 Clinical Trial.

7

Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.

Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S. Eikelboom JW, et al. Circulation. 2005 Dec 20;112(25):3855-67. doi: 10.1161/CIRCULATIONAHA.105.573550. Epub 2005 Dec 12. Circulation. 2005. PMID: 16344381

8

ESPRIT trial.

O'Donnell M, Eikelboom JW. O'Donnell M, et al. Among authors: eikelboom jw. Lancet. 2006 Aug 5;368(9534):447; author reply 449. doi: 10.1016/S0140-6736(06)69144-7. Lancet. 2006. PMID: 16890824 No abstract available.

9

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Eikelboom JW, et al. Circulation. 2006 Aug 22;114(8):774-82. doi: 10.1161/CIRCULATIONAHA.106.612812. Epub 2006 Aug 14. Circulation. 2006. PMID: 16908769

10

Pexelizumab does not "complement" percutaneous coronary intervention in patients with ST-elevation myocardial infarction.

Eikelboom JW, O'Donnell M. Eikelboom JW, et al. JAMA. 2007 Jan 3;297(1):91-2. doi: 10.1001/jama.297.1.91. JAMA. 2007. PMID: 17200480 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters